Supriya Lifescience Ltd reports Q2 FY27 revenue of ₹206.3 crore, up 3.2% YoY, while net profit fell 42% to ₹29.25 crore.
- EBITDA was ₹45.4 crore, down 37.5% YoY; EBITDA margin was 22.0%, down 1,435 bps YoY.
- Revenue rose 8.7% sequentially; net profit increased 21.7% QoQ.
- The company presented unaudited Q2 and H1 FY27 results for the period ended September 30, 2026.